http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101125210-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 |
| filingDate | 2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101125210-B1 |
| titleOfInvention | Aripiprazole-bentonite-AEA hybrid, pharmaceutical composition containing the same, and preparation method thereof |
| abstract | The present invention relates to an aripiprazole-bentonite-AEA hybrid, a pharmaceutical composition containing the same, and a preparation method thereof, wherein the aripiprazole-bentonite-AEA hybrid according to the present invention exhibits high solubility while masking bitter taste, thereby improving absorption in the body. It can be usefully used as an active ingredient in the pharmaceutical composition for treating mental disorders, including schizophrenia and bipolar disorder.n n n n Aripiprazole, Bentonite, AEA, Nanohybrid, Gummy Shield, Mental Illness Treatment |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014025206-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160139704-A |
| priorityDate | 2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.